| Financial Year |
March 31 2023 |
| Monetary Funds |
361,013,533.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
307,582,008.56 |
| Accounts Receivable |
86,071,854.52 |
| Advances to Suppliers |
70,285,854.66 |
| Other Receivables |
193,894,093.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
543,965,010.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,124,684.26 |
| Total Current Assets |
1,703,861,447.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,893,028,368.07 |
| Under-construction Projects |
153,747,487.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
373,493,009.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,457,569.75 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
3,893,612.76 |
| Sub-Total of Non-Current Assets |
5,445,960,082.49 |
| Total Assets |
7,149,821,530.12 |
| Short-Term Loans |
306,740,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,183,505.97 |
| Accounts Payable |
525,751,570.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,326,406.40 |
| Taxes Payable |
47,916,628.22 |
| Interest Payable |
-- |
| Dividend Payable |
55,869,942.39 |
| Other payables |
321,959,704.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,014,871.49 |
| Other Current Liabilities |
307,618,163.60 |
| Sub-Total of Current Liabilities |
1,842,377,640.34 |
| Long-term Loans |
911,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,846,402.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
974,458,079.37 |
| Total Liabilities |
2,816,835,719.71 |
| Paid-In Capital(Or Share Stock) |
418,355,802.00 |
| Capital Surplus |
573,723,996.84 |
| Surplus Reserve |
266,882,040.47 |
| LESS:Treasury Stock |
36,746,418.00 |
| Undistributed Profits |
2,791,807,446.81 |
| Minority Stockholder's Interest |
316,301,229.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,016,684,580.42 |
| Owner's Equity（Stockholder's Equity） |
4,332,985,810.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,149,821,530.12 |
